$PPCB 52-week-low 033?! 52WKH 90 cents! #biotech Shorts Decreased by 93%
PROPANC BIOPHARMA INC (OTCMKTS:PPCB) Shorts Decreased by 93% After Short Covering THIS BIOTECH GEM IS UNKNOWN. ONLY 38 MILLION O\S. I REPEAT ONLY 38 MILLION O\S. Won't be unknown for long
Propanc Biopharma, Inc., a development stage healthcare company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. The company has market cap of $1.86 million. The companyÂ’s lead product includes PRP, a patented formulation consisting of two pro-enzymes, such as trypsinogen and chymotrypsinogen, as well as the enzyme amylase designed to synergistically enhance anti-cancer effects. It currently has negative earnings. It is also developing a combination of anti-cancer agents working in combination with pro-enzymes, which enhance PRPÂ’s anti-cancer effects.
PPCB PPCB PPCB PPCB PPCB PPCB PPCB PPCB PPCB PPCB
PPCB PPCB PPCB PPCB PPCB PPCB PPCB PPCB PPCB PPCB
PPCB PPCB PPCB PPCB PPCB PPCB PPCB PPCB PPCB PPCB
Everything I post is only my opinion. Please do your own DD and do not make any investment and/or trading decisions based on anything I say as it is all just my opinion.
